
    
      This is a single-arm, non-randomized trial of oxaliplatin and capecitabine. Patients that are
      placed on other studies that utilize the same chemotherapy regimen can enter this study.
      Those patients will be treated according to the clinical study on which they have been
      entered. For patients not on another clinical trial, the treatment outlined below should be
      followed.
    
  